110 related articles for article (PubMed ID: 17545520)
1. Methylation and silencing of protein tyrosine phosphatase receptor type O in chronic lymphocytic leukemia.
Motiwala T; Majumder S; Kutay H; Smith DS; Neuberg DS; Lucas DM; Byrd JC; Grever M; Jacob ST
Clin Cancer Res; 2007 Jun; 13(11):3174-81. PubMed ID: 17545520
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas.
Motiwala T; Ghoshal K; Das A; Majumder S; Weichenhan D; Wu YZ; Holman K; James SJ; Jacob ST; Plass C
Oncogene; 2003 Sep; 22(41):6319-31. PubMed ID: 14508512
[TBL] [Abstract][Full Text] [Related]
3. Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment.
Zhang X; Wang H; Zhang Y; Wang X
Clin Exp Med; 2024 Mar; 24(1):54. PubMed ID: 38492089
[TBL] [Abstract][Full Text] [Related]
4. Investigating the potential of single-cell DNA methylation data to detect allele-specific methylation and imprinting.
Johnson ND; Cutler DJ; Conneely KN
Am J Hum Genet; 2024 Apr; 111(4):654-667. PubMed ID: 38471507
[TBL] [Abstract][Full Text] [Related]
5. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective.
Peters FS; Strefford JC; Eldering E; Kater AP
Haematologica; 2021 May; 106(5):1234-1243. PubMed ID: 33691381
[TBL] [Abstract][Full Text] [Related]
6. Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia.
Su X; Lucas DM; Zhang L; Xu H; Zabrouskov V; Davis ME; Knapp AR; Young DC; Payne PR; Parthun MR; Marcucci G; Grever MR; Byrd JC; Freitas MA
Proteomics; 2009 Mar; 9(5):1197-206. PubMed ID: 19253275
[TBL] [Abstract][Full Text] [Related]
7. Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia.
Shalek AK; Gaublomme JT; Wang L; Yosef N; Chevrier N; Andersen MS; Robinson JT; Pochet N; Neuberg D; Gertner RS; Amit I; Brown JR; Hacohen N; Regev A; Wu CJ; Park H
Nano Lett; 2012 Dec; 12(12):6498-504. PubMed ID: 23190424
[TBL] [Abstract][Full Text] [Related]
8. The Role of Methylation in Chronic Lymphocytic Leukemia and Its Prognostic and Therapeutic Impacts in the Disease: A Systematic Review.
Chatzidavid S; Kontandreopoulou CN; Giannakopoulou N; Diamantopoulos PT; Stafylidis C; Kyrtsonis MC; Dimou M; Panayiotidis P; Viniou NA
Adv Hematol; 2024; 2024():1370364. PubMed ID: 38435839
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis.
Dai Y; Shi S; Liu H; Zhou H; Ding W; Liu C; Jin L; Xie W; Kong H; Zhang Q
Cell Death Dis; 2024 Jan; 15(1):11. PubMed ID: 38182570
[TBL] [Abstract][Full Text] [Related]
10. Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment.
Yao Z; Dong H; Zhu J; Du L; Luo Y; Liu Q; Liu S; Lin Y; Wang L; Wang S; Wei W; Zhang K; Huang Q; Yu X; Zhao W; Xu H; Qiu X; Pan Y; Huang X; Jim Yeung SC; Zhang D; Zhang H
JCI Insight; 2023 Jul; 8(14):. PubMed ID: 37485875
[TBL] [Abstract][Full Text] [Related]
11. Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia.
Pagano MA; Frezzato F; Visentin A; Trentin L; Brunati AM
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230804
[TBL] [Abstract][Full Text] [Related]
12. Glycerophosphoinositol Promotes Apoptosis of Chronic Lymphocytic Leukemia Cells by Enhancing Bax Expression and Activation.
Boncompagni G; Varone A; Tatangelo V; Capitani N; Frezzato F; Visentin A; Trentin L; Corda D; Baldari CT; Patrussi L
Front Oncol; 2022; 12():835290. PubMed ID: 35392232
[TBL] [Abstract][Full Text] [Related]
13. PTPRO is a therapeutic target and correlated with immune infiltrates in pancreatic cancer.
Hou X; Du J; Fang H
J Cancer; 2021; 12(24):7445-7453. PubMed ID: 35003364
[TBL] [Abstract][Full Text] [Related]
14. Regulatory Functions of Protein Tyrosine Phosphatase Receptor Type O in Immune Cells.
Xie F; Dong H; Zhang H
Front Immunol; 2021; 12():783370. PubMed ID: 34880876
[TBL] [Abstract][Full Text] [Related]
15. The Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma.
Huang Y; Zhang Y; Ge L; Lin Y; Kwok HF
Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29558404
[TBL] [Abstract][Full Text] [Related]
16. Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma.
Wang H; Baladandayuthapani V; Wang Z; Lin H; Berkova Z; Davis RE; Yang L; Orlowski RZ
Oncotarget; 2017 Dec; 8(69):113858-113873. PubMed ID: 29371952
[TBL] [Abstract][Full Text] [Related]
17. Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells.
Tibaldi E; Pagano MA; Frezzato F; Trimarco V; Facco M; Zagotto G; Ribaudo G; Pavan V; Bordin L; Visentin A; Zonta F; Semenzato G; Brunati AM; Trentin L
Haematologica; 2017 Aug; 102(8):1401-1412. PubMed ID: 28619847
[TBL] [Abstract][Full Text] [Related]
18. Epigenetically silenced PTPRO functions as a prognostic marker and tumor suppressor in human lung squamous cell carcinoma.
Ming F; Sun Q
Mol Med Rep; 2017 Jul; 16(1):746-754. PubMed ID: 28586036
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
